CD36‐Binding Amphiphilic Nanoparticles for Attenuation of α‐Synuclein‐Induced Microglial Activation-Reference-Cited by-同舟云学术

CD36‐Binding Amphiphilic Nanoparticles for Attenuation of α‐Synuclein‐Induced Microglial Activation

Published:2022-03-22 Issue:6 Volume:2 Page:2100120
ISSN:2699-9307
Container-title:Advanced NanoBiomed Research
language:en
Short-container-title:Advanced NanoBiomed Research

Author:

Zhao Nanxia¹,Francis Nicola L.²,Song Shuang³,Kholodovych Vladyslav⁴,Calvelli Hannah R.⁵,Hoop Cody L.⁶,Pang Zhiping P.⁷⁸,Baum Jean⁵,Uhrich Kathryn E.³,Moghe Prabhas V.¹²⁹¹⁰^ORCID

Affiliation:

1. Department of Chemical and Biochemical Engineering Rutgers University 98 Brett Rd Piscataway NJ 08854 USA

2. Department of Biomedical Engineering Rutgers University 599 Taylor Rd. Piscataway NJ 08854 USA

3. Department of Chemistry University of California 501 Big Springs Rd. Riverside CA 92507 USA

4. Office of Advanced Research Computing Rutgers University 96 Frelinghuysen Road Piscataway NJ 08854 USA

5. Department of Molecular Biology & Biochemistry Rutgers University 604 Allison Rd Piscataway NJ 08854 USA

6. Department of Chemistry & Chemical Biology Rutgers University 123 Bevier Rd Piscataway NJ 08854 USA

7. Department of Neuroscience and Cell Biology Rutgers Robert Wood Johnson Medical School Rutgers University 604 Allison Rd Piscataway NJ 08854 USA

8. Child Health Institute of New Jersey 89 French St New Brunswick NJ 08901 USA

9. Department of Chemical and Biochemical Engineering Rutgers University 98 Brett Road Piscataway NJ 08854 USA

10. Department of Biomedical Engineering Rutgers University 599 Taylor Road Piscataway NJ 08854 USA

Funder

National Institute of Neurological Disorders and Stroke

National Science Foundation

National Institute on Aging

National Institute of General Medical Sciences

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/anbr.202100120

Reference49 articles.

1. Clearance and deposition of extracellular α-synuclein aggregates in microglia

2. Current and projected future economic burden of Parkinson’s disease in the U.S.

3. Zeroing in on neurodegenerative α-synuclein

4. Immunotherapy in Parkinson’s disease: Current status and future directions

5. Soluble α-synuclein–antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing nanomedicine for modulating microglial states in the central nervous system disorders: Challenges and opportunities;Biomedicine & Pharmacotherapy;2024-08

2. Cluster of Differentiation 36 (CD36) Preferentially Mediates Intestinal Absorption of Dietary Z-Astaxanthin and Especially 9-Z-Isomer via Higher Binding Affinity;Journal of Agricultural and Food Chemistry;2024-07-10

3. Nanotechnology for microglial targeting and inhibition of neuroinflammation underlying Alzheimer’s pathology;Translational Neurodegeneration;2024-01-04

4. Neuronanomedicine for Alzheimer’s and Parkinson’s disease: Current progress and a guide to improve clinical translation;Brain, Behavior, and Immunity;2024-01

5. Biomaterial strategies for regulating the neuroinflammatory response;Materials Advances;2024